GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Energenesis Biomedical Co Ltd (TPE:6657) » Definitions » Institutional Ownership

Energenesis Biomedical Co (TPE:6657) Institutional Ownership : 0.09% (As of Jun. 25, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Energenesis Biomedical Co Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Energenesis Biomedical Co's institutional ownership is 0.09%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Energenesis Biomedical Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Energenesis Biomedical Co's Float Percentage Of Total Shares Outstanding is 0.00%.


Energenesis Biomedical Co Institutional Ownership Historical Data

The historical data trend for Energenesis Biomedical Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Energenesis Biomedical Co Institutional Ownership Chart

Energenesis Biomedical Co Historical Data

The historical data trend for Energenesis Biomedical Co can be seen below:

2024-04-30 2024-06-30 2024-08-31 2024-09-30 2024-10-31 2024-12-31 2025-01-31 2025-02-28 2025-03-31 2025-05-31
Institutional Ownership 0.13 0.10 0.10 0.10 0.09 0.11 0.09 0.09 0.09 0.09

Energenesis Biomedical Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Energenesis Biomedical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 21, Lane 583, Ruiguang Road, 6th Floor -3, Neihu District, Taipei, TWN, 11492
Energenesis Biomedical Co Ltd is a biomedicine company. It is engaged in businesses related to biological experimentation and analysis, as well as new drug development. The company uses its ENERGI drug development platform to activate AMP-activated protein kinase (AMPK), a key enzyme in cell energy regulation, as a means of developing disease treatments. Its product pipeline consists of ENERGI-F703, a diabetic foot ulcers treatment gel; ENERGI-F701, a product developed for male hair loss; ENERGI-F704, an inflammatory bowel disease treatment; and ENERGI-F711, a burn cream, among others.

Energenesis Biomedical Co Headlines

No Headlines